Overview
Matthew Zibelman is an Oncologist in Philadelphia, Pennsylvania. Dr. Zibelman is highly rated in 15 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Endoscopy.
His clinical research consists of co-authoring 74 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
333 Cottman Ave, Philadelphia, PA 19111
333 Cottman Ave, Philadelphia, PA 19111
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Fox Chase Cancer Center Medical Group Inc
Hossein Borghaei is an Oncologist in Philadelphia, Pennsylvania. Dr. Borghaei is highly rated in 18 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Fox Chase Cancer Center
Daniel Geynisman is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Temple University Hospital-Jeanes Campus
Elizabeth Plimack is an Oncologist in Philadelphia, Pennsylvania. Dr. Plimack is highly rated in 15 conditions, according to our data. Her top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Frequently Asked Questions about Dr. Matthew Zibelman
How do I make an appointment with Dr. Matthew Zibelman?
You can book an appointment with Dr. Matthew Zibelman by calling their office at 215-728-2500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew Zibelman a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew Zibelman is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew Zibelman specialize in?
While Dr. Matthew Zibelman is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Matthew Zibelman participate in research or clinical trials?
Yes. Dr. Matthew Zibelman has published 74 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Matthew Zibelman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew Zibelman accept my insurance?
Dr. Matthew Zibelman accepts most major insurance plans, including Aetna and Avalon Health Care. We recommend calling the office directly at 215-728-2500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)Dr. Zibelman isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Bladder CancerDr. Zibelman isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Zibelman isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Zibelman isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Zibelman isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Zibelman isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Zibelman isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Zibelman isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- MelanomaDr. Zibelman isAdvanced. Learn about Melanoma.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- AngiosarcomaDr. Zibelman isExperienced. Learn about Angiosarcoma.
- Angiosarcoma of the ScalpDr. Zibelman isExperienced. Learn about Angiosarcoma of the Scalp.
- Breast CancerDr. Zibelman isExperienced. Learn about Breast Cancer.
- ChoriocarcinomaDr. Zibelman isExperienced. Learn about Choriocarcinoma.
- Colorectal CancerDr. Zibelman isExperienced. Learn about Colorectal Cancer.
- EndoscopyDr. Zibelman isExperienced. Learn about Endoscopy.